Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-120,830
Closed -$6.89M 345
2020
Q2
$6.89M Buy
120,830
+45,420
+60% +$2.23M 0.43% 75
2020
Q1
$2.65M Sell
75,410
-30,176
-29% -$1.44M 0.32% 79
2019
Q4
$5.51M Buy
+105,586
New +$5.26M 0.4% 70
2013
Q3
Sell
-400,000
Closed -$7.72M 277
2013
Q2
$7.72M Buy
+400,000
New +$8.36M 0.79% 30

Other funds holding HOLX

J. Goldman & Co's HOLX Position: Q3 2020 in Review

J. Goldman & Co sold out of Hologic (HOLX) in Q3 2020, closing a stake of 120,830 shares — an estimated $6.89M sold.

J. Goldman & Co first reported a position in HOLX in Q2 2013 and held it in 4 quarters. The position peaked at $7.72M in Q2 2013. 566 funds tracked by Wall St. Rank hold HOLX as of Q3 2020.

  • J. Goldman & Co reported no remaining Hologic position as of Q3 2020 after selling out during the quarter.
  • J. Goldman & Co sold 120,830 Hologic shares in Q3 2020, an estimated $6.89M.
  • J. Goldman & Co first reported a position in Hologic in Q2 2013 and held it in 4 quarters.
  • J. Goldman & Co's Hologic position peaked at $7.72M in Q2 2013.
  • 566 funds tracked by Wall St. Rank held Hologic as of Q3 2020.

Based on J. Goldman & Co's 13F filing for Q3 2020, filed 16 Nov 2020.